


News
Impact Expansion Invests in SomniPlanet
Impact Expansion invests in SomniPlanet to scale homecare sleep apnea treatments and expand its data-driven healthcare model.
Impact Expansion is pleased to announce that it has reached an agreement to acquire a minority stake in SomniPlanet, a French-based company providing homecare treatments to patients suffering from sleep apnea. New funds will support a buy-and-build strategy in France and Impact Expansion expects to deploy up to €15m over time. Financial terms were not disclosed.
SomniPlanet is headquartered in Neuilly-sur-Seine (France) and was founded in 2017 by its current management team led by Yann Goïot, Olivier Félix and Johann Sasco. Its primary mission is to better treat a rapidly increasing number of patients suffering from sleep apnea.
According to a recent research study, this under-diagnosed chronic disease has become a major healthcare challenge affecting one in three people worldwide and leading to co-morbidities such as high blood pressure, heart disease, diabetes, hypertension and stroke. Today, SomniPlanet treats several thousands of patients located in the Ile-de-France region and plans to grow nationally.
SomniPlanet has developed its own proprietary data-driven integrated model, delivering superior patients’ adherence to treatment, high patient well-being and satisfaction with proven health and cost outcomes. This proprietary model also helps doctors in their day-to-day work, allowing them to spend more time with their patients.
SomniPlanet works with doctors, nurses and psychologists to better engage patients, having a direct positive impact on their compliance rates. SomniPlanet’s integrated collaborative platform was designed to onboard other homecare services such as nutrition, diabetes, perfusion, ventilation and insulin therapies affecting millions of patients, costing more than €3bn per year to the French healthcare system.
SomniPlanet contributes to SDG #3 (good health and well-being), SDG #8 (decent work and economic growth) and SDG #9 (industry, innovation and infrastructure).
Since its foundation, SomniPlanet has collaborated in several clinical studies relating to sleep, remote patient monitoring in disease management, and sleep tech. As such, SomniPlanet is perceived as an innovative company paving the way to future connected healthcare models.
Yann Goïot, CEO SomniPlanet, commented: “We are very pleased to welcome Impact Expansion at our side. Today’s investment will enable us to accelerate our growth in other regions while continuing to develop our suite of data and AI-powered solutions as well as develop new partnerships. We will expand upon a truly personalised sleep patient management service to transform the patient’s and physician’s experience”.
Jérôme Fournier Le Ray, Partner Impact Expansion, said: “Impact Expansion is delighted to provide additional resources to SomniPlanet so more patients suffering from obstructive sleep apnea will benefit from a better treatment, and more doctors will be able to monitor their patients through the innovative MySomniPlanet platform. SomniPlanet has become a reference in terms of quality of healthcare services thanks to its visionary management team. This is the second investment of our new Impact Expansion Fund and therefore an important milestone for our team”.
About Impact Expansion
Impact Expansion is an independent investment manager based in Luxembourg, sponsored by KOIS, a pioneer in impact investing, with offices in Brussels and Paris, and whose purpose is to invest in the following three themes:
(i) structural unemployment, investing in sectors such as education and training, social inclusion and youth employment among others
(ii) environment, investing in companies bringing solutions to the fight against the climate crisis, pollution and the decline of biodiversity and to promote a circular economy
(iii) health, with the objective to enhance access to the best quality care
Impact Expansion takes minority and majority ownership positions through €5 to €20 million equity investments in companies located in Western Europe. The team’s leading expertise in impact combined with strong private equity discipline aims at generating superior impact and tier-one financial returns.
Contacts
Elvire Perrin (Investor Relations): elvire@impact-expansion.com / +32 480 62 73 23
François de Borchgrave (Partner): francois@impact-expansion.com / +32 474 83 22 44
Jérôme Fournier Le Ray (Partner): jerome@impact-expansion.com / +33 6 31 30 62 23
For more information:
www.impact-expansion.com
Deal team
SomniPlanet: Yann Goïot, Olivier Félix, Riad Sifi
Impact Expansion: Jérôme Fournier Le Ray, Philippe Croppi, Ladislas de Guerre
Strategic DD: AMR International: Florent Jarry, Jason Diab
Financial DD: 2CFinance: Jacques Haccoun, Claire Jacinto
Impact Expansion’s legal advisors: Jeantet & Associés: Pascal Georges, David Hallel
SomniPlanet’s legal advisors: EY Ventury Avocats: Nicolas Ivaldi, Cécilia Nervo
Impact Expansion is pleased to announce that it has reached an agreement to acquire a minority stake in SomniPlanet, a French-based company providing homecare treatments to patients suffering from sleep apnea. New funds will support a buy-and-build strategy in France and Impact Expansion expects to deploy up to €15m over time. Financial terms were not disclosed.
SomniPlanet is headquartered in Neuilly-sur-Seine (France) and was founded in 2017 by its current management team led by Yann Goïot, Olivier Félix and Johann Sasco. Its primary mission is to better treat a rapidly increasing number of patients suffering from sleep apnea.
According to a recent research study, this under-diagnosed chronic disease has become a major healthcare challenge affecting one in three people worldwide and leading to co-morbidities such as high blood pressure, heart disease, diabetes, hypertension and stroke. Today, SomniPlanet treats several thousands of patients located in the Ile-de-France region and plans to grow nationally.
SomniPlanet has developed its own proprietary data-driven integrated model, delivering superior patients’ adherence to treatment, high patient well-being and satisfaction with proven health and cost outcomes. This proprietary model also helps doctors in their day-to-day work, allowing them to spend more time with their patients.
SomniPlanet works with doctors, nurses and psychologists to better engage patients, having a direct positive impact on their compliance rates. SomniPlanet’s integrated collaborative platform was designed to onboard other homecare services such as nutrition, diabetes, perfusion, ventilation and insulin therapies affecting millions of patients, costing more than €3bn per year to the French healthcare system.
SomniPlanet contributes to SDG #3 (good health and well-being), SDG #8 (decent work and economic growth) and SDG #9 (industry, innovation and infrastructure).
Since its foundation, SomniPlanet has collaborated in several clinical studies relating to sleep, remote patient monitoring in disease management, and sleep tech. As such, SomniPlanet is perceived as an innovative company paving the way to future connected healthcare models.
Yann Goïot, CEO SomniPlanet, commented: “We are very pleased to welcome Impact Expansion at our side. Today’s investment will enable us to accelerate our growth in other regions while continuing to develop our suite of data and AI-powered solutions as well as develop new partnerships. We will expand upon a truly personalised sleep patient management service to transform the patient’s and physician’s experience”.
Jérôme Fournier Le Ray, Partner Impact Expansion, said: “Impact Expansion is delighted to provide additional resources to SomniPlanet so more patients suffering from obstructive sleep apnea will benefit from a better treatment, and more doctors will be able to monitor their patients through the innovative MySomniPlanet platform. SomniPlanet has become a reference in terms of quality of healthcare services thanks to its visionary management team. This is the second investment of our new Impact Expansion Fund and therefore an important milestone for our team”.
About Impact Expansion
Impact Expansion is an independent investment manager based in Luxembourg, sponsored by KOIS, a pioneer in impact investing, with offices in Brussels and Paris, and whose purpose is to invest in the following three themes:
(i) structural unemployment, investing in sectors such as education and training, social inclusion and youth employment among others
(ii) environment, investing in companies bringing solutions to the fight against the climate crisis, pollution and the decline of biodiversity and to promote a circular economy
(iii) health, with the objective to enhance access to the best quality care
Impact Expansion takes minority and majority ownership positions through €5 to €20 million equity investments in companies located in Western Europe. The team’s leading expertise in impact combined with strong private equity discipline aims at generating superior impact and tier-one financial returns.
Contacts
Elvire Perrin (Investor Relations): elvire@impact-expansion.com / +32 480 62 73 23
François de Borchgrave (Partner): francois@impact-expansion.com / +32 474 83 22 44
Jérôme Fournier Le Ray (Partner): jerome@impact-expansion.com / +33 6 31 30 62 23
For more information:
www.impact-expansion.com
Deal team
SomniPlanet: Yann Goïot, Olivier Félix, Riad Sifi
Impact Expansion: Jérôme Fournier Le Ray, Philippe Croppi, Ladislas de Guerre
Strategic DD: AMR International: Florent Jarry, Jason Diab
Financial DD: 2CFinance: Jacques Haccoun, Claire Jacinto
Impact Expansion’s legal advisors: Jeantet & Associés: Pascal Georges, David Hallel
SomniPlanet’s legal advisors: EY Ventury Avocats: Nicolas Ivaldi, Cécilia Nervo



